论文部分内容阅读
通过检测52例肺癌患者治疗前血清可溶性白细胞介素2受体水平与正常健康人群对比。结果显示肺癌患者治疗前血清SIL—2R水平显著提高，与正常对照组比较有显著意义。
The pre-treatment serum soluble interleukin 2 receptor levels in 52 patients with lung cancer were compared with normal healthy people. The results showed that the serum SIL-2R levels were significantly increased before treatment in patients with lung cancer, and there was a significant difference compared with the normal control group.